Eyetelligence, an Australian startup that uses retinal imaging to diagnose diseases, raised $12M from Ascertain.
The company currently offers service via Bupa Optical and optometry chain George & Matilda.
- "The three most common eye diseases — diabetic retinopathy, age-related macular degeneration, and glaucoma — can be detected far earlier with algorithmic retinal image analysis. These three diseases, however, are just the tip of the iceberg," said University of Melbourne Professor Mingguang He, who co-founded the startup with Jason Sun.
- Eyeintelligence also has its algorithms in utilization in New Zealand, Europe, and Japan.
- The company is the first international investment by Ascertain, which is a partnership between venture studio Aegis Ventures and New York-based Northwell Health system.
- The startup previously raised ~$2.24M through a Seed round in 2021.